Society of Neuroimmune Pharmacology Inc

Society of Neuroimmune Pharmacology Inc

Washington, DC, US
501(c)3
EIN
58-2586479

Society of Neuroimmune Pharmacology Inc

Washington, DC, US
501(c)3
EIN
58-2586479

Income Statement

Fiscal Year Start:
Jan 1
Revenues in 2024

$113,784

Program Services
54%
Contributions
46%
Investments
<1%
Government Grants
0%
Fundraising Events
0%
Membership Dues
0%
Other
0%
Expenses in 2024

$103,132

Other
97%
Fees to Service Providers
3%
Grants
0%
Benefits to Members
0%
Salaries & Benefits
0%
Advertising & Promotion
0%
Offices, Occupancy & IT
0%
Interest
0%
Depreciation
0%
Revenues
2023
2024
Change
Contributions
$28,025
$52,500
+87%
Government Grants
$0
$0
-
Fundraising Events
$0
$0
-
Program Services
$33,162
$61,274
+85%
Membership Dues
$0
$0
-
Investments
$14
$10
-29%
Other
$0
$0
-
Total Revenues
$61,201
$113,784
+86%
Expenses
2023
2024
Change
Grants
$0
$0
-
Benefits to Members
$0
$0
-
Salaries & Benefits
$0
$0
-
Fees to Service Providers
$6,980
$3,200
-54%
Advertising & Promotion
$0
$0
-
Offices, Occupancy & IT
$0
$0
-
Interest
$0
$0
-
Depreciation
$0
$0
-
Other
$128,761
$99,932
-22%
Total Expenses
$135,741
$103,132
-24%
Net income
2023
2024
Change
Net income
-$74,540
+$10,652
-114%
Income Statement
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)